A simple and rapid laboratory method for determination of haemostasis potential in plasma: II. Modifications for use in routine laboratories and research work

Thrombosis Research

Volumn 103, Issue 5, 2001, Pages 355-361

  He, S ^a   Antovic, A ^a   Blomback M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Acetylsalicylic acid; Coronary heart disease; Fibrin aggregation; Haemostasis; Method; Pre eclampsia

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRIN; FIBRINOGEN; PROTHROMBIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; ASSAY; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LABORATORY TEST; MALE; PLASMA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; VALIDATION PROCESS;

ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL FACTORS; BLOOD COAGULATION TESTS; CORONARY DISEASE; FEMALE; HEMOSTASIS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; MIDDLE AGED; MODELS, THEORETICAL; PRE-ECLAMPSIA; PREGNANCY; REFERENCE VALUES; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0035448605     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00332-2     Document Type: Article

References (12)

1. A laboratory method for determination of overall haemostatic potential in plasma: I. Method design and preliminary results
2. Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid
3. Gerinungsphysiologische schnellmethode zur bestimmung des fibrinogens
4. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey: I. Illustrative references ranges by age, sex and hormone use
5. Hypercoagulability in centenarians: The paradox of successful aging
6. Haemostatic function in myocardial infarction
7. Enhanced thrombin generation and fibrinolysis activity in the normal pregnancy and purerperium
8. Pathological processes in pregnancy-induced hypertension and intrauterine growth retardation: 'An excess of heated blood'
9. Fibrin D-dimmer levels in preeclamptic pregnancies with birth of small-for-gestational-age neonates
10. Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
11. Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?
12. Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?